When asked to review this work my first reaction was to decline. I suspected, correctly, that some of the chapters would have an irritating, smug tone. Having spent many years in clinical trials and meta-analyses of cancer treatment I am in no doubt about either the value of randomized trials or the statistical imperatives for trial size and design that follow from the moderate benefits of treatment to be expected in malignant and degenerative processes. So I am not antagonistic to the central ideas expressed in these essays. The collection is, however, a missed opportunity because of what has been left out. The 'nonrandom' in the title signifies a bias in favour of enthusiasts.
The first few chapters are some personal recollections of Cochrane. I do not know his work and found the glimpses of the man fairly interesting (though doctors, in my opinion, tend to overestimate the wisdom of other doctors). Cochrane wrote his own obituary, which is re-published in the volume. Even if intended as a joke it is curiously immodest. There are some good reviews although they tend to repeat what has been written on many occasions. Rory Collins and colleagues offer an especially lucid explanation of the need for some large trials and overviews. I recommend this to all who teach on the design and statistics of trials. There is an interesting comparison (from Chalmers and colleagues) of the size of the treatment benefits suggested by randomized and non-randomized studies-a useful source of ammunition for those who need to argue against unrandomized studies. What a pity there is no chapter analysing the latest dottiness in health service research, namely the use of 'outcome measures' derived from databases of cases as a means of determining the effect of introduction of a treatment. If you want to find out what it is like to belong to a profession which, as a whole, does not believe in randomized assessment ofintervention, read Geraldine Macdonald's contribution on the state of research in social work. It's fascinating.
The notion of quality adjusted life years (QALYs) is explained by Alan Williams. I found it as flawed as ever. I was at a meeting on quality of life assessment in cancer trials recently where a health economist assumed that the time on treatment was not to be counted as worthwhile quality of life. Treatments may take a long time in cancer and vary greatly in their toxicity; most patients get on quite well with their life during the treatment period. Why assume that life is not worthwhile during this time? Among the other reviews are discussion of the benefits of drinking alcohol (Richard Doll) and an account of the multiple benefits of aspirin (Peter Elwood). There are two essays on the distribution of resources and equity in medical care, one of which is locked into QALYs as a measure of outcome.
Perhaps this volume should be taken at its face value a tribute to the man after whom the collaborative effort of information sharing is named. From this point of view it is pleasant to dip into. But I was hoping it would tell us about the relationship between the discovery of new agents, or of the first trial of a bright idea, and the way these are introduced into the clinic. In addition, the authors might have acknowledged how small is the contribution some trials make to clinical decision making for individual patients. For example, in our hospital we participate in a very large scale trial of chemotherapy in non-small-cell lung cancer which is open to every patient irrespective of stage. The issue is important since the value of this treatment is still widely debated. All the patients are assessed by the same team, who are enthusiasts for the study, yet we randomize less than 20%. For the others there are social or medical reasons why the treatment should be given or withheld. The endpoint of the trial is survival. If there is a difference whose size can be reasonably estimated, clinicians will be helped by this knowledge, but it will be only one factor in the decision to treat a patient. How do we use this information from the trial (which represents a truth but one which must be tempered for each patient) to make general statements about whether the treatment concerned is better or worse value than money spent on some other aspect of medicine? It is these clinical concerns which, when omitted from discussion, lead clinicians to become irritated by some advocates of evidence-based medicine and health economic assessment.
The volume contains no discussion of the reasons for the indifferent quality of some health services research or of how it might be made to appeal to really able young researchers. There is much to be gained by a marriage of this form of research with modern science such as population genetics. Would evidence-based decisions for treatment of individual patients, made with the aid of algorithms based on the best available data from trials via the Cochrane collaboration and other sources, give better outcomes than ordinary clinical judgment? This collection gives numerous examples of the restricted points of view which could be modified by the world of clinical experience. There is a telling example of this when the story is recounted by different contributors of how pleased Cochrane was when a trial of coronary care units suggested that they were associated with a higher mortality than care at home. But the introduction of these units was based on several arguments for changing the pattern of care. The trial result was swept away when excellent reasons were offered for doubting the conclusions drawn from the study. Who would wish to have their myocardial infarction teated at home nowadays? The editors of this enjoyable collection assembled enthusiasts but no critics. : 1941-1943, subtitled The Wartime Experience of an Army Surgeon in the Gold Coast, with some trepidation. In the course of some recent research I have read accounts of the experiences of RAMC officers that have left a lasting impression of the horror of war and of the acute physical and human suffering which it engenders. I was therefore agreeably surprised to find that Bush Proper is no Heart of Darkness but rather provides scenes of a life of relative normalityscenes that are as varied and as vibrant with each turn of a page as the images of a shaken kaleidoscope. The author's preface explains how this archive of bygone days of colonial rule has been pieced together from the letters which he wrote home during his service in Africa. The opening chapter gives a glimpse of life in wartime Britain. There are some charming character cameos and
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